84. サルコイドーシス
[臨床試験数:143,薬物数:221(DrugBank:79),標的遺伝子数:82,標的パスウェイ数:165

Searched query = "Sarcoidosis"
The queries were searched in Public_title, Scientific_title, and Condition. Export date: 03/15/2021. Trials are sorted by Date_enrollment from most recent to oldest in the table.

Search in Page e.g. "Phase 3", "Not recruiting", "Japan"
2 trials found
No.TrialIDDate_
enrollment
Date_
registration
Public_titleScientific_titleConditionInterventionPrimary_
sponsor
Secondary_
sponsor
Recruitment_
Status
Inclusion_
agemin
Inclusion_
agemax
Inclusion_
gender
Target_
size
PhaseCountries
1JPRN-UMIN000025936
2017/06/1220/02/2017Japanese AntibaCterial drug maNagemEnt for cardiac Sarcoidosis Trial Cardiac sarcoidosiscombination therapy group:
Prednisolone; Predonisolone start from 30mg/day and continue same dose for one month. After one month, prednisolone decrease 25mg, 20mg, 15mg, 10mg every 2-4 weeks. Finally, maintenance dose of predonisolone is 7.5mg.
Antimicrobial agent; Clarithromycin start from 400mg/day for 24weeks. Doxycycline start 100mg/day for 22 weeks after 2 months of clarithromycin therapy.

Prednisolone; Predonisolone start from 30mg/day and continue same dose for one month. After one month, prednisolone decrease 25mg, 20mg, 15mg, 10mg every 2-4 weeks. Finally, maintenance dose of predonisolone is 7.5mg.
National cerebral and cardiovascular centerNULLRecruiting20years-oldNot applicableMale and Female80Not selectedJapan
2JPRN-jRCTs031180301
01/05/201715/03/2019Antibacterial therapy for severe sarcoid uveitisStudy of antibacterial therapy for severe uveitis by sarcoidosis Severe uveitis by sarcoidosis
Other eyes and adnexal disease
Ordinary steroid medication with Clarithromycin and minomycinTakase HiroshiNULLSuspended20age80ageBoth10Phase 1-2Japan